Search research articles
Contact Us
Filters
Showing results (21-30 of 31) with videos related to
Page
of 4
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 1, 1995
Phase II trial of docetaxel in patients with advanced cutaneous malignant melanoma previously untreated with chemotherapy
A Y Bedikian, G R Weiss, S S Legha, et al.
Melanoma Research
|
June 4, 1998
DNA damage in peripheral blood mononuclear cells correlates with response to biochemotherapy in melanoma
A C Buzaid, F Ali-Osman, N Akande, et al.
Melanoma Research
|
June 4, 1998
Nitric oxide and neopterin levels and clinical response in stage III melanoma patients receiving concurrent biochemotherapy
C M Anderson, A C Buzaid, J Sussman, et al.
Melanoma Research
|
January 26, 1999
Phase II study of neoadjuvant concurrent biochemotherapy in melanoma patients with local-regional metastases
A C Buzaid, M Colome, A Bedikian, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 1997
Critical analysis of the current American Joint Committee on Cancer staging system for cutaneous melanoma and proposal of a new staging system
A C Buzaid, M I Ross, C M Balch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 21, 1998
Prognostic factors for survival of patients treated systemically for disseminated melanoma
O Eton, S S Legha, T E Moon, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy
|
May 1, 1996
Phase Ia/Ib trial of anti-GD2 chimeric monoclonal antibody 14.18 (ch14.18) and recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) in metastatic melanoma
J L Murray, E S Kleinerman, S F Jia, et al.
Cancer Research
|
October 20, 2020
Nanoengineered Disruption of Heat Shock Protein 90 Targets Drug-Induced Resistance and Relieves Natural Killer Cell Suppression in Breast Cancer
Munisha Smalley, Siva Kumar Natarajan, Jayanta Mondal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 14, 1998
Active immunotherapy with ultraviolet B-irradiated autologous whole melanoma cells plus DETOX in patients with metastatic melanoma
O Eton, D D Kharkevitch, M A Gianan, et al.
British Journal of Cancer
|
August 30, 2008
Phase II trial of imatinib mesylate in patients with metastatic melanoma
K B Kim, O Eton, D W Davis, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 31) with videos related to
Sort By:
Page
of 4
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 1, 1995
Phase II trial of docetaxel in patients with advanced cutaneous malignant melanoma previously untreated with chemotherapy
A Y Bedikian, G R Weiss, S S Legha, et al.
Melanoma Research
|
June 4, 1998
DNA damage in peripheral blood mononuclear cells correlates with response to biochemotherapy in melanoma
A C Buzaid, F Ali-Osman, N Akande, et al.
Melanoma Research
|
June 4, 1998
Nitric oxide and neopterin levels and clinical response in stage III melanoma patients receiving concurrent biochemotherapy
C M Anderson, A C Buzaid, J Sussman, et al.
Melanoma Research
|
January 26, 1999
Phase II study of neoadjuvant concurrent biochemotherapy in melanoma patients with local-regional metastases
A C Buzaid, M Colome, A Bedikian, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 1997
Critical analysis of the current American Joint Committee on Cancer staging system for cutaneous melanoma and proposal of a new staging system
A C Buzaid, M I Ross, C M Balch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 21, 1998
Prognostic factors for survival of patients treated systemically for disseminated melanoma
O Eton, S S Legha, T E Moon, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy
|
May 1, 1996
Phase Ia/Ib trial of anti-GD2 chimeric monoclonal antibody 14.18 (ch14.18) and recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) in metastatic melanoma
J L Murray, E S Kleinerman, S F Jia, et al.
Cancer Research
|
October 20, 2020
Nanoengineered Disruption of Heat Shock Protein 90 Targets Drug-Induced Resistance and Relieves Natural Killer Cell Suppression in Breast Cancer
Munisha Smalley, Siva Kumar Natarajan, Jayanta Mondal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 14, 1998
Active immunotherapy with ultraviolet B-irradiated autologous whole melanoma cells plus DETOX in patients with metastatic melanoma
O Eton, D D Kharkevitch, M A Gianan, et al.
British Journal of Cancer
|
August 30, 2008
Phase II trial of imatinib mesylate in patients with metastatic melanoma
K B Kim, O Eton, D W Davis, et al.
Page
of 4